123 related articles for article (PubMed ID: 2540581)
21. The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancer.
Vinante O; Bari M; Segati R; Azzarello G; Sampognaro E; Rosetti F; Pappagallo GL
Oncology; 1993; 50(1):1-4. PubMed ID: 8380631
[TBL] [Abstract][Full Text] [Related]
22. Preliminary experience with mitomycin, vinblastine and cisplatin (MVP) combination chemotherapy in the treatment of advanced non-small cell lung cancer at University Hospital, Kuala Lumpur.
Lee SM
Singapore Med J; 1990 Jun; 31(3):228-32. PubMed ID: 2168091
[TBL] [Abstract][Full Text] [Related]
23. Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Gridelli C; Perrone F; Palmeri S; D'Aprile M; Cognetti F; Rossi A; Gebbia V; Pepe R; Veltri E; Airoma G; Russo A; Incoronato P; Scinto AF; Palazzolo G; Natali M; Leonardi V; Gallo C; De Placido S; Bianco AR
Ann Oncol; 1996 Oct; 7(8):821-6. PubMed ID: 8922196
[TBL] [Abstract][Full Text] [Related]
24. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
25. Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
Nomura F; Shimokata K; Saito H; Sakai S; Watanabe A; Saka H
Cancer Chemother Pharmacol; 1987; 20(4):324-6. PubMed ID: 2826032
[TBL] [Abstract][Full Text] [Related]
26. Lonidamine in non-small-cell lung cancer: a phase II study.
Contu A; Olmeo NA; Pani P; Deriu A; Ortu S; Paga C
Tumori; 1991 Feb; 77(1):52-5. PubMed ID: 1850177
[TBL] [Abstract][Full Text] [Related]
27. Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancer.
Ferrigno D; Buccheri G
Acta Oncol; 1996; 35(4):435-9. PubMed ID: 8695157
[TBL] [Abstract][Full Text] [Related]
28. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
29. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
[TBL] [Abstract][Full Text] [Related]
30. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
Pisters KM; Kris MG; Gralla RJ; Zaman MB; Heelan RT; Martini N
J Clin Oncol; 1993 Sep; 11(9):1757-62. PubMed ID: 8394881
[TBL] [Abstract][Full Text] [Related]
31. A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
Shinkai T; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Kojima A; Oshita F; Saijo N
Eur J Cancer; 1991; 27(5):571-5. PubMed ID: 1647183
[TBL] [Abstract][Full Text] [Related]
32. Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.
Smith IE; O'Brien ME; Talbot DC; Nicolson MC; Mansi JL; Hickish TF; Norton A; Ashley S
J Clin Oncol; 2001 Mar; 19(5):1336-43. PubMed ID: 11230476
[TBL] [Abstract][Full Text] [Related]
33. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
[TBL] [Abstract][Full Text] [Related]
34. Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
Giaccone G; Bagatella M; Donadio M; Bonardi GM; Testore F; Ferrati P; Ciuffreda L; Calciati A
Br J Cancer; 1987 Oct; 56(4):475-8. PubMed ID: 2825750
[TBL] [Abstract][Full Text] [Related]
35. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
36. Treatment of inoperable non-small cell lung carcinoma stage IIIb and IV with cisplatin, epidoxorubicin, vindesine and lonidamine: a phase II study.
Portalone L; Lombardi A; Antilli A; Cruciani AR; Magliacani V; Mugnaini L; Nunziati F; Perrone N; Signora M; Salvati F
Tumori; 1999; 85(4):239-42. PubMed ID: 10587024
[TBL] [Abstract][Full Text] [Related]
37. A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
Ann Oncol; 1992 Feb; 3(2):127-30. PubMed ID: 1318742
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Setoguchi J; Sawada M; Onodera H; Sigeta M; Nakai M; Nakano K; Kanatsuna T; Kondoh M; Hotta T; Hayashi H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
[TBL] [Abstract][Full Text] [Related]
39. Mitomycin-C, vinblastine, and lonidamine as salvage treatment of advanced breast cancer. A pilot study.
Zaniboni A; Montini E; Simoncini E; Marpicati P; Arcangeli G; Meriggi F; Marini G
Am J Clin Oncol; 1990 Dec; 13(6):520-3. PubMed ID: 2122716
[TBL] [Abstract][Full Text] [Related]
40. Mitomycin C, vinblastine and carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC).
Gregory RK; Smith IE; Norton A; Ashley S; O'Brien ME
Clin Oncol (R Coll Radiol); 2001; 13(6):483-7. PubMed ID: 11824893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
